Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy

Por Sportès, Claude, Babb, Rebecca R., Krumlauf, Michael C., Hakim, Frances T., Steinberg, Seth M., Chow, Catherine K., Brown, Margaret R., Fleisher, Thomas A., Noel, Pierre, Maric, Irina, Stetler-Stevenson, Maryalice, Engel, Julie, Buffet, Renaud, Morre, Michel, Amato, Robert J, Pecora, Andrew, Mackall, Crystal L., Gress, Ronald E.
Publicado em 2010

Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets

Por Sportès, Claude, Hakim, Frances T., Memon, Sarfraz A., Zhang, Hua, Chua, Kevin S., Brown, Margaret R., Fleisher, Thomas A., Krumlauf, Michael C., Babb, Rebecca R., Chow, Catherine K., Fry, Terry J., Engels, Julie, Buffet, Renaud, Morre, Michel, Amato, Robert J., Venzon, David J., Korngold, Robert, Pecora, Andrew, Gress, Ronald E., Mackall, Crystal L.
Publicado em 2008

Phase I Trial of Adoptive Cell Transfer with Mixed-Profile Type-I/Type-II Allogeneic T Cells for Metastatic Breast Cancer

Por Hardy, Nancy M., Mossoba, Miriam E., Steinberg, Seth M., Fellowes, Vicki, Yan, Xiao-Yi, Hakim, Frances T., Babb, Rebecca R., Avila, Daniele, Gea-Banacloche, Juan, Sportès, Claude, Levine, Bruce L., June, Carl H., Khuu, Hahn M., Carpenter, Ashley E., Krumlauf, Michael C., Dwyer, Andrew J., Gress, Ronald E., Fowler, Daniel H., Bishop, Michael R.
Publicado em 2011